Supporting Treatment Access and Recovery in COD
Part of paid clinical trials in Holyoke, Massachusetts.
- Sponsor
- University of Massachusetts, Worcester
- Study ID
- NCT05138614
- Status
- Recruiting
Conditions
- Mental Health Disorder
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Medication for Opioid Use Disorder — OTHERmedication management
- MISSION Critical Time Intervention — BEHAVIORALoffering intensive community-based services that decrease in intensity over time
- MISSION Peer Support — BEHAVIORALincluding 11 recovery-oriented sessions from someone with lived experience of co-occurring disorders
- MISSION Dual Recovery Therapy — BEHAVIORALcomprised of 13 structured co-occurring disorders treatment sessions
Study Details
This 4-year study will randomize 1,000 people with co-occurring opioid use and mental health disorders (COD) at medication for opioid use disorder (MOUD) clinics to evaluate the effectiveness of MISSION, a multi-component team approach, or its components with MOUD versus MOUD alone, as well as the incremental benefits of MISSION or its components for improving outcomes. We expect that individuals receiving MISSION or its parts + MOUD will show greater improvement over MOUD alone on: engagement, substance use, and mental health.
Key Dates
- Start date
- Mar 11, 2022
- Status verified
- Jun 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Full MISSIONCTI + DRT + PS + MOUD
- Experimental: CTI & DRTCTI + DRT + MOUD
- Experimental: CTI & PSCTI + PS + MOUD
- Experimental: DRT & PSDRT + PS + MOUD
- Other: MOUD onlyMOUD
Primary Outcome Measure
Engagement in treatment [ Time Frame: 6 months ]
Central Contacts
- David Smelson, PsyD508-713-5420
- Abigail Helm, PhD413-313-2806
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Behavioral Health Network | Holyoke | Massachusetts | 01040 | Herschelle Reaves |
| Behavioral Health Network | Orange | Massachusetts | 01364 | Calla Harrington |
| Behavioral Health Network | Springfield | Massachusetts | 01104 | Herschelle Reaves |
| SaVida Health | Worcester | Massachusetts | 01605 | Shelley Modzeleski |
| UMass Chan Road to Care Clinic | Worcester | Massachusetts | 01601 | Brittany Chapman |
Find similar trials in Holyoke, MA
Related Studies
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized TrialNot Yet Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ StudyRecruiting · Boston Medical Center · Boston, Massachusetts
- Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUDRecruiting · Brigham and Women's Hospital · Boston, Massachusetts